Receptor-mediated |
|
|
|
|
TNF-α
|
MCF-7 breast carcinoma cells |
+ |
+ |
[107] |
|
L929 fibroblasts |
+ |
+ |
[107] |
|
HL-60 promyelocytic leukaemia cells |
+ |
+ |
[108] |
TNF-α/cycloheximide |
Cerebral endothelial cells |
+ |
+ |
[109] |
B-cell receptor cross-linking |
Ramos B-cells |
+ |
+ |
[110] |
T-cell receptor cross-linking |
T-cell hybridoma |
N/D |
+ |
[111] |
Cancer chemotherapeutic agents |
|
|
|
|
Camptothecin |
4B1 (human Fas-expressing L929 mouse fibroblasts) |
N/D |
+ |
[112] |
|
FTC-133 follicular thyroid carcinoma cells |
+ |
+ |
[97] |
Doxorubicin |
MCF-7 breast carcinoma cells |
N/D |
+ |
[113] |
|
Rat primary astrocytes |
N/D |
+ |
[114] |
|
FTC-133 follicular thyroid carcinoma cells |
+ |
+ |
[97] |
Daunorubicin |
P388 lymphocytic leukaemia cells |
+ |
+ |
[60] |
|
Hen follicular granulosa cells |
N/D |
+ |
[115] |
Etoposide |
MOLT4 leukaemia cells |
+ |
+ |
[116] |
Fenretinide (4-HPR) |
HL-60 promyelocytic leukaemia |
+ |
+ |
[117] |
|
Endothelial cells |
+ |
+ |
[118] |
Fludarabine |
Chronic B-cell leukaemia |
+ |
+ |
[119] |
|
LNCaP prostate cancer cells |
+ |
+ |
[120] |
Inostamycin |
Ms-1 small cell lung carcinoma cells |
+ |
+ |
[121] |
Oxaliplatin + SK inhibitor |
RKO colon carcinoma cells |
+ |
+ |
[122] |
Vascular endothelial growth factor inhibitor SU5416 |
Mouse lung |
N/D |
+ |
[101] |
IR and non-IR |
|
|
|
|
γ-Irradiation |
Mouse colonic crypts |
N/D |
+ |
[105] |
|
Human lymphoblasts |
+ |
+ |
[123] |
|
LNCaP prostate cancer cells |
+ |
+ |
[106] |
125I-Labelled 5-iodo-29-deoxyuridine |
Bovine aortic endothelial cells |
+ |
+ |
[102] |
UV-B |
Human keratinocytes |
+ |
+ |
[100] |
UV-C |
Hen follicular granulosa cells |
N/D |
+ |
[115] |